BioLife Solutions, Inc.
BLFS
$23.89
$0.602.58%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 831.59% | 92.52% | -122.83% | 31.66% | 48.66% |
| Total Depreciation and Amortization | -163.27% | -5.20% | 67.97% | 163.76% | -171.83% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -288.56% | -77.59% | 462.83% | -69.75% | -39.89% |
| Change in Net Operating Assets | 170.02% | -146.38% | -- | -- | 364.76% |
| Cash from Operations | -65.74% | -25.65% | 244.34% | -293.64% | 152.77% |
| Capital Expenditure | 48.19% | -288.78% | -- | -- | 0.54% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 56,069.17% | 99.07% | -6,350.23% | -103.49% | 56.22% |
| Cash from Investing | 4,480.55% | 87.49% | -5,979.19% | -105.59% | 138.09% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -26.23% | -1,226.14% | -- | -- | 143.33% |
| Issuance of Common Stock | 41.30% | -- | -- | -- | 16,120.31% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -144.56% | 272.17% | 0.74% | -31.31% | -174.67% |
| Cash from Financing | -292.51% | -47.87% | 26.05% | -109.67% | 1,518.59% |
| Foreign Exchange rate Adjustments | -19.44% | -- | 100.00% | -203.17% | 212.50% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3,266.02% | 127.55% | -34.43% | -135.33% | 846.97% |